Cubist Systematic Strategies’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,152
Closed -$22.9K 2461
2024
Q3
$22.9K Sell
6,152
-19,660
-76% -$73.3K ﹤0.01% 1314
2024
Q2
$145K Buy
+25,812
New +$145K ﹤0.01% 1130
2024
Q1
Sell
-15,228
Closed -$79.6K 2919
2023
Q4
$79.6K Sell
15,228
-43,303
-74% -$226K ﹤0.01% 1814
2023
Q3
$923K Sell
58,531
-15,977
-21% -$252K 0.01% 1071
2023
Q2
$1.45M Buy
74,508
+36,440
+96% +$708K 0.01% 1029
2023
Q1
$1.08M Buy
38,068
+31,881
+515% +$904K 0.01% 1435
2022
Q4
$181K Buy
+6,187
New +$181K ﹤0.01% 2687
2022
Q3
Sell
-9,658
Closed -$429K 3982
2022
Q2
$429K Sell
9,658
-3,021
-24% -$134K ﹤0.01% 2715
2022
Q1
$627K Buy
12,679
+4,356
+52% +$215K 0.01% 2370
2021
Q4
$424K Sell
8,323
-4,357
-34% -$222K ﹤0.01% 2568
2021
Q3
$707K Buy
12,680
+4,346
+52% +$242K 0.01% 1788
2021
Q2
$357K Sell
8,334
-7,667
-48% -$328K ﹤0.01% 2226
2021
Q1
$668K Buy
16,001
+7,401
+86% +$309K 0.01% 1793
2020
Q4
$401K Buy
8,600
+2,734
+47% +$127K 0.01% 1896
2020
Q3
$249K Buy
+5,866
New +$249K ﹤0.01% 2047
2020
Q2
Sell
-5,463
Closed -$251K 2558
2020
Q1
$251K Buy
+5,463
New +$251K 0.01% 1607
2019
Q4
Sell
-5,862
Closed -$332K 2581
2019
Q3
$332K Sell
5,862
-2,815
-32% -$159K 0.01% 1507
2019
Q2
$483K Buy
8,677
+214
+3% +$11.9K 0.01% 1494
2019
Q1
$427K Sell
8,463
-15,043
-64% -$759K 0.01% 1288
2018
Q4
$947K Buy
+23,506
New +$947K 0.04% 585
2017
Q4
Sell
-6,554
Closed -$391K 2136
2017
Q3
$391K Buy
6,554
+2,852
+77% +$170K 0.02% 980
2017
Q2
$292K Buy
+3,702
New +$292K 0.02% 1054
2016
Q2
Sell
-1,378
Closed -$56K 1919
2016
Q1
$56K Buy
+1,378
New +$56K ﹤0.01% 1466
2015
Q4
Sell
-3,962
Closed -$293K 1981
2015
Q3
$293K Buy
3,962
+344
+10% +$25.4K 0.01% 1243
2015
Q2
$293K Sell
3,618
-22,354
-86% -$1.81M 0.01% 1234
2015
Q1
$1.09M Buy
+25,972
New +$1.09M 0.05% 526